Related Experiment Videos
Can we predict sudden cardiac death?
T Meinertz1, T Hofmann, M Zehender
1Department of Cardiology, St George Hospital, Hamburg, Federal Republic of Germany.
Insights
Identifying patients at risk of sudden cardiac death (SCD) is challenging, with current methods identifying only 30-40%. Advanced investigations are crucial for high-risk individuals, including those with cardiomyopathy or coronary artery disease.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Electrophysiology
Background:
- Sudden cardiac death (SCD) remains a significant concern, with limited ability to predict events in asymptomatic individuals.
- Traditional risk factors like hypertension and high cholesterol have low predictive value for SCD in the general population.
- Certain conditions, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and coronary artery disease, are associated with increased SCD risk.
Purpose of the Study:
- To review current methods for identifying patients at risk of sudden cardiac death.
- To highlight key risk factors and diagnostic tools for various cardiac conditions.
- To stratify patients into low, medium, and high risk categories for SCD.
Main Methods:
- Review of existing literature on risk factors and predictive markers for sudden cardiac death.
- Analysis of diagnostic approaches for asymptomatic individuals, patients with cardiomyopathies, and those with coronary artery disease.
- Evaluation of electrocardiography (ECG), Holter monitoring, signal-averaged ECG, and electrophysiological testing.
Main Results:
- Abnormal resting or exercise ECGs, familial history, and lifestyle factors are recognized risk factors but have low predictive value.
- In hypertrophic cardiomyopathy, risk factors include family history, syncope, and age; ventricular tachycardia on Holter monitoring indicates higher risk.
- In dilated cardiomyopathy, frequent ventricular arrhythmias and reduced ejection fraction predict SCD risk.
- Coronary artery disease patients at risk are identified through coronary anatomy, ventricular function, ischemia, late potentials, arrhythmias, and electrophysiological testing results, allowing risk stratification.
Conclusions:
- Accurate prediction of sudden cardiac death remains a clinical challenge, necessitating a multi-faceted approach.
- Risk stratification for sudden cardiac death is possible in specific patient groups, particularly those with underlying cardiac disease.
- Further research and refined diagnostic strategies are needed to improve the identification and prevention of sudden cardiac death.
Abstract:
Up to now only 30 to 40% of patients who die suddenly can be identified as likely candidates before the event. Risk factors in these asymptomatic subjects include a familial history of coronary artery disease, high blood cholesterol levels, hypertension, smoking and, more importantly, an abnormal ECG at rest or during exercise. The predictive value of these abnormalities is too low to justify more detailed clinical investigations in most of these asymptomatic subjects. Exceptions might be the group of patients with multiple risk factors and competitive sportsmen. Sudden cardiac death is a well known complication in patients with hypertrophic and dilated cardiomyopathy. Risk factors in hypertrophic cardiomyopathy include a familial history of this disease, syncope and increasing age. Furthermore, in the adult, the presence of nonsustained episodes of ventricular tachycardia during Holter monitoring seems to indicate an increased risk of sudden cardiac death. In idiopathic dilated cardiomyopathy, the presence of frequent episodes of ventricular pairs and/or episodes of ventricular tachycardia during Holter monitoring, together with a reduced left ventricular ejection fraction, characterises the patient at risk of sudden cardiac death. In patients with coronary artery disease, the patient at risk of sudden cardiac death can be identified by investigating the following: coronary anatomy; global and regional left ventricular function; the presence of ischaemia during rest and/or exercise; the presence of late potentials, by means of the signal-averaged ECG; the presence of spontaneous ventricular arrhythmias (especially sustained and nonsustained ventricular tachycardia); and the results of electrophysiological testing. On the basis of these investigations, 3 subgroups can be distinguished: patients at low risk, medium risk, and high risk of sudden cardiac death.